ADIPOQ and metabolic syndrome: A 12-week, open-label multicenter study performed among 103 consecutive patients with hypercholesterolemia showed that patients with MetS (n = 69) had significantly higher mean levels of plasma high-sensitivity C-reactive protein and significantly lower mean levels of high-molecular-weight adiponectin than their counterparts without MetS (n = 34) [51].